Amyl nitrates are linked to prolonged bilateral vision loss and retinal damage.

Article

Recreational drugs amyl nitrate and isopropyl nitrate (poppers) are associated with bilateral vision loss and retinal disorders due to damage of the foveal cone outer segments.

Recreational drugs amyl nitrate and isopropyl nitrate (poppers) are associated with bilateral vision loss and retinal disorders due to damage of the foveal cone outer segments, according to a study released by the Archives of Ophthalmology.

A team lead by Dr Isabelle Audo, Clinical Investigation Center, Université Pierre et Marie Curie-Paris, France, conducted a restrospective, observational case series on 6 patients with bilateral vision loss after chronic use of amyl or isopropyl nitrates. The outcome measures included: symptoms, medical history, ophthalmic examination and functional and morphological tests.

All patients examined presented with progressive bilateral vision loss. Two patients experienced central photopsia and initial visual acuities varied from 20/50 to 20/25.

In each patient a bilateral yellow foveal spot was found and was linked to the disruption of the foveal cones' outer segments. After discontinued use of poppers, 4 patients demonstrated significant anatomical and functional improvement.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.